Key Points Question What are the epidemiologic trends of and prognostic factors for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in patients in the US? Findings In this cohort study of 43 751 patients… Click to show full abstract
Key Points Question What are the epidemiologic trends of and prognostic factors for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in patients in the US? Findings In this cohort study of 43 751 patients with GEP-NETs, most cases occurred in the rectum and small intestine. The age-adjusted incidence rate of GEP-NETs increased significantly from 1975 to 2015, especially for rectal, localized, and grade 1 GEP-NETs; age, sex, marital status and tumor size, grade, stage, and site were significantly associated with overall survival for patients with GEP-NETs. Meaning The incidence and prevalence of GEP-NETs have continued to increase over 40 years; this study suggests that a predictive model based on prognostic factors may accurately quantify the risk of death among patients with GEP-NETs, indicating that the model has satisfactory clinical practicality.
               
Click one of the above tabs to view related content.